Literature DB >> 16081902

Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching.

Shi-Lu Luan1, Margareta Granlund, Mats Sellin, Teresa Lagergård, Brian G Spratt, Mari Norgren.   

Abstract

Streptococcus agalactiae, also designated group B streptococcus (GBS), is an important pathogen in neonates, pregnant women, and nonpregnant adults with predisposing conditions. We used multilocus sequence typing (MLST) to characterize 158 GBS isolates that were associated with neonatal and adult invasive disease and that were collected in northern and western Sweden from 1988 to 1997. Five major genetic lineages (sequence type [ST] 19, ST-17, ST-1, ST-23, and ST-9 complexes) were identified among the isolates, including serotype Ia, Ib, and II to V isolates, indicating a highly clonal population structure among invasive GBS isolates. A number of STs were found to contain isolates of different serotypes, which indicates that capsule switching occurred rather frequently. Two distantly related genetic lineages were identified among isolates of serotype III, namely, clonal complex 19 (CC19), and CC17. CC19 was equally common among isolates from adult and neonatal disease (accounting for 10.3% of GBS isolates from adult disease and 18.7% from neonatal disease), whereas CC17 significantly appeared to be associated with neonatal invasive disease (isolated from 21.9% of neonatal isolates but only 2.6% of adult isolates). The distribution of the mobile elements GBSi1 and IS1548 reveals that they can act as genetic markers for lineages CC17 and CC19, respectively.

Entities:  

Mesh:

Year:  2005        PMID: 16081902      PMCID: PMC1233917          DOI: 10.1128/JCM.43.8.3727-3733.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenes.

Authors:  Awdhesh Kalia; Brian G Spratt; Mark C Enright; Debra E Bessen
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Multilocus sequence typing of Bordetella pertussis based on surface protein genes.

Authors:  Inge H M van Loo; Kees J Heuvelman; Audrey J King; Frits R Mooi
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 3.  The emergence of group B streptococci in infections of the newborn infant.

Authors:  B F Anthony; D M Okada
Journal:  Annu Rev Med       Date:  1977       Impact factor: 13.739

4.  eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data.

Authors:  Edward J Feil; Bao C Li; David M Aanensen; William P Hanage; Brian G Spratt
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

5.  Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae.

Authors:  Elisabeth E Adderson; Shinji Takahashi; Yan Wang; Jianling Armstrong; Dylan V Miller; John F Bohnsack
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

6.  Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential.

Authors:  H Dele Davies; Nicola Jones; Thomas S Whittam; Sameer Elsayed; Naiel Bisharat; Carol J Baker
Journal:  J Infect Dis       Date:  2004-02-27       Impact factor: 5.226

7.  Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease.

Authors:  Philippe Glaser; Christophe Rusniok; Carmen Buchrieser; Fabien Chevalier; Lionel Frangeul; Tarek Msadek; Mohamed Zouine; Elisabeth Couvé; Lila Lalioui; Claire Poyart; Patrick Trieu-Cuot; Frank Kunst
Journal:  Mol Microbiol       Date:  2002-09       Impact factor: 3.501

8.  Multilocus sequence typing system for group B streptococcus.

Authors:  Nicola Jones; John F Bohnsack; Shinji Takahashi; Karen A Oliver; Man-Suen Chan; Frank Kunst; Philippe Glaser; Christophe Rusniok; Derrick W M Crook; Rosalind M Harding; Naiel Bisharat; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

9.  An inserted DNA fragment with plasmid features is uniquely associated with the presence of the GBSi1 group II intron in Streptococcus agalactiae.

Authors:  Shi-Lu Luan; Margareta Granlund; Mari Norgren
Journal:  Gene       Date:  2003-07-17       Impact factor: 3.688

10.  Serotype III Streptococcus agalactiae from bovine milk and human neonatal infections.

Authors:  John F Bohnsack; April A Whiting; Gabriela Martinez; Nicola Jones; Elisabeth E Adderson; Shauna Detrick; Anne J Blaschke-Bonkowsky; Naiel Bisharat; Marcelo Gottschalk
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

View more
  86 in total

1.  Antimicrobial resistance in colonizing group B Streptococci before the implementation of a Swedish intrapartum antibiotic prophylaxis program.

Authors:  M Granlund; P Axemo; K Bremme; A-L Bryngelsson; M Carlsson Wallin; C-M Ekström; S Håkansson; B Jacobsson; K Källén; E Spetz; I Tessin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-13       Impact factor: 3.267

2.  Rapid multiple-locus variant-repeat assay (MLVA) for genotyping of Streptococcus agalactiae.

Authors:  Andreas Radtke; Bjørn-Arne Lindstedt; Jan Egil Afset; Kåre Bergh
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

3.  High-virulence clone of group B streptococci unable to grow at high temperatures is present in serotypes other than type III.

Authors:  Gerardo C Palacios; Maria N Gonzalez; Magdalena Beltran; Jose L Arredondo; Javier Torres; Fortino Solorzano
Journal:  Curr Microbiol       Date:  2006-12-13       Impact factor: 2.188

4.  Mobile genetic elements provide evidence for a bovine origin of clonal complex 17 of Streptococcus agalactiae.

Authors:  Geneviève Héry-Arnaud; Guillaume Bruant; Philippe Lanotte; Stella Brun; Bertrand Picard; Agnès Rosenau; Nathalie van der Mee-Marquet; Pascal Rainard; Roland Quentin; Laurent Mereghetti
Journal:  Appl Environ Microbiol       Date:  2007-05-25       Impact factor: 4.792

5.  Streptococcus agalactiae serotype Ib as an agent of meningitis in two adult nonpregnant women.

Authors:  E R Martins; C Florindo; F Martins; I Aldir; M J Borrego; L Brum; M Ramirez; J Melo-Cristino
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

6.  Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999.

Authors:  John F Bohnsack; April Whiting; Marcelo Gottschalk; Diane Marie Dunn; Robert Weiss; Parvin H Azimi; Joseph B Philips; Leonard E Weisman; George G Rhoads; Feng-Ying C Lin
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

7.  Reevaluating the serotype II capsular locus of Streptococcus agalactiae.

Authors:  E R Martins; J Melo-Cristino; M Ramirez
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

8.  Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1.

Authors:  Francesco Doro; Sabrina Liberatori; Manuel J Rodríguez-Ortega; Cira D Rinaudo; Roberto Rosini; Marirosa Mora; Maria Scarselli; Emrah Altindis; Romina D'Aurizio; Maria Stella; Immaculada Margarit; Domenico Maione; John L Telford; Nathalie Norais; Guido Grandi
Journal:  Mol Cell Proteomics       Date:  2009-04-28       Impact factor: 5.911

9.  Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.

Authors:  Mary Meehan; Robert Cunney; Mary Cafferkey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-28       Impact factor: 3.267

10.  Modulation of Death and Inflammatory Signaling in Decidual Stromal Cells following Exposure to Group B Streptococcus.

Authors:  Rebecca A Flaherty; Maja Magel; David M Aronoff; Jennifer A Gaddy; Margaret G Petroff; Shannon D Manning
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.